Upcoming Meetings: Rep. Shays blood safety hearing
This article was originally published in The Gray Sheet
Executive Summary
Rep. Shays blood safety hearing: House Government Reform/Human Resources Subcommittee Chair Christopher Shays (R-Conn.) schedules second oversight hearing Nov. 2 to address "efforts by the government and blood products industry to protect the nation's blood supply from emerging infectious agents." Topics to be addressed include "the role of blood industries in ensuring the safety of blood and blood products, industry quality standards, and the application of new manufacturing technologies that may improve product safety." Witnesses include representatives from the Centers for Disease Control and Prevention, the National Institutes of Health, the American Red Cross, Bayer Corp. and Baxter Healthcare...
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.